Comparison of adriamycin (NSC-123127) and 5-fluorouracil (NSC-19893) in advanced prostatic cancer.
作者信息
DeWys W D
出版信息
Cancer Chemother Rep. 1975 Jan-Feb;59(1):215-7.
PMID:1093668
Abstract
摘要
相似文献
1
Comparison of adriamycin (NSC-123127) and 5-fluorouracil (NSC-19893) in advanced prostatic cancer.阿霉素（NSC - 123127）与5 - 氟尿嘧啶（NSC - 19893）在晚期前列腺癌中的比较。
Cancer Chemother Rep. 1975 Jan-Feb;59(1):215-7.
2
Comparative trial of adriamycin and 5-fluorouracil in advanced prostatic cancer--progress report.阿霉素与5-氟尿嘧啶治疗晚期前列腺癌的对比试验——进展报告
Cancer Treat Rep. 1977 Mar-Apr;61(2):325-8.
3
A comparative clinical trial of adriamycin and 5-fluorouracil in advanced prostatic cancer: prognostic factors and response.阿霉素与5-氟尿嘧啶治疗晚期前列腺癌的比较临床试验：预后因素与反应
Prostate. 1983;4(1):1-11. doi: 10.1002/pros.2990040102.
4
Comparison of adriamycin (NSC-123127) and the combination of 5-fluorouracil (NSC-19893) and cyclophosphamide (NSC-26271) in advanced prostatic cancer: a preliminary report.
Cancer Chemother Rep. 1975 Jan-Feb;59(1):203-7.
5
Adriamycin (NSC-123127) versus 5-fluorouracil (NSC-19893) and cyclophosphamide (NSC-26271) in the treatment of metastatic prostate cancer.
Cancer Treat Rep. 1976 Jan;60(1):115-7.
6
Initial chemotherapeutic trials in patients with inoperable or recurrent cancer of the prostate.针对无法进行手术或复发性前列腺癌患者的初始化疗试验。
Cancer Chemother Rep. 1975 Jan-Feb;59(1):243-9.
7
Chemotherapy of advanced carcinoma of the prostate with 5-fluorouracil, cyclophosphamide and adriamycin.
J Urol. 1976 Jan;115(1):86-8. doi: 10.1016/s0022-5347(17)59077-1.
8
Doxorubicin hydrochloride, cyclophosphamide, and 5-fluorouracil combination in advanced prostate and transitional cell carcinoma.
Urology. 1976 Nov;8(5):459-64. doi: 10.1016/0090-4295(76)90275-2.
9
10
Proceedings: Non-hormonal cytotoxic agents in the treatment of prostatic adenocarcinoma.会议论文：非激素细胞毒性药物治疗前列腺腺癌
Cancer. 1973 Nov;32(5):1131-40. doi: 10.1002/1097-0142(197311)32:5<1131::aid-cncr2820320519>3.0.co;2-n.
Zotero 插件